Welcome to LookChem.com Sign In|Join Free

CAS

  • or

52979-42-7

Post Buying Request

52979-42-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

52979-42-7 Usage

General Description

Methyl 6-amino-4-oxo-1,4-dihydroquinoline-2-carboxylate is a chemical compound with the molecular formula C13H12N2O3. It is a quinoline derivative and is commonly used in pharmaceutical research and drug development. Methyl 6-aMino-4-oxo-1,4-dihydroquinoline-2-carboxylate has been studied for its potential use in treating various medical conditions, including bacterial and viral infections, as well as cancer. Its molecular structure makes it a promising candidate for the development of new drugs with potential therapeutic benefits. The synthesis and characterization of this compound have been the subject of various scientific studies focused on its potential pharmaceutical applications. Overall, methyl 6-amino-4-oxo-1,4-dihydroquinoline-2-carboxylate is an important compound in medicinal chemistry research.

Check Digit Verification of cas no

The CAS Registry Mumber 52979-42-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,9,7 and 9 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 52979-42:
(7*5)+(6*2)+(5*9)+(4*7)+(3*9)+(2*4)+(1*2)=157
157 % 10 = 7
So 52979-42-7 is a valid CAS Registry Number.

52979-42-7Relevant articles and documents

Novel vitexin-inspired scaffold against leukemia

Ling, Taotao,Lang, Walter,Feng, Xiang,Das, Sourav,Maier, Julie,Jeffries, Cynthia,Shelat, Anang,Rivas, Fatima

, p. 501 - 510 (2018/02/15)

Acute lymphoblastic leukemia (ALL) is the most common type of leukemia in children. Up to a quarter of ALL patients relapse and face poor prognosis. To identify new compound leads, we conducted a phenotypic screen using terrestrial natural product (NP) fr

2-AMINOCARBONYL-QUINOLINE COMPOUNDS AS PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS

-

Page 42, (2010/02/07)

Compounds of formula (I), where m, n, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compounds are also described herein.

Kynurenic acid derivatives inhibit the binding of nerve growth factor (NGF) to the low-affinity p75 NGF receptor

Jaen,Laborde,Bucsh,Caprathe,Sorenson,Fergus,Spiegel,Marks,Dickerson,Davis

, p. 4439 - 4445 (2007/10/03)

The ability of a series of substituted kynurenic acids, thienopyridinonecarboxylic acids, and related compounds to inhibit the binding of nerve growth factor (NGF) to the p75 NGF receptor (NGFR) was evaluated in a radioligand binding assay that utilized a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 52979-42-7